Clinical Evidence on GLP-1 and Corticosteroid Co-Administration Limited prospective clinical trials directly study GLP-1 and corticosteroid interactions, but case reports and observational data highlight increased glucose variability and reduced weight loss during concurrent use
ingredients: aqua/water/eau, macadamia ternifolia seed oil, isocetyl stearoyl stearate, caprylic/capric triglyceride, glycerin, dimethicone, olea europaea (olive) fruit oil, parfum/fragrance, cetearyl alcohol, cetearyl glucoside, cetyl alcohol, stearyl alcohol, butyrospermum parkii (shea) butter, stearic acid, phenoxyethanol, caprylyl glycol, benzophenone-3, tocopheryl acetate, xanthan gum, acrylates/c10-30 alkyl acrylate crosspolymer, potassium sorbate, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, sodium hydroxide, hexylene glycol, hydroxycitronellal, disodium edta, limonene, bht, linalool, citric acid
In a late-stage clinical trial, a drug similar to Ozempic was shown to reduce body mass index in kids ages 6 to 11 with obesity, according to results published Tuesday in the New England Journal of Medicine
10.1021/jf071328f J
[33] also evaluated corneal nerve density and length by scan and sweat chloride concentrations and used the questionnaire for neuropathic pain (DN4)
The honest conclusion: if the goal is improving sleep quality in a healthy adult, approved and OTC options have stronger evidence, established safety profiles, and no requirement for injection